Last reviewed · How we verify
Postpartum hemorrhage
Approved treatments
- Oxytocin 5 Usp Units In Dextrose 5% · Fresenius Kabi
- Ergobasine · Cairo University
- Methergine · Edison Theraps Llc
- Cytotec · Pfizer
Diclofenac inhibits COX-1/COX-2 to reduce prostaglandins; misoprostol is PGE1 analog protecting gastric mucosa. - Hemabate · Pfizer
- Cytotec · Generic (originally Searle/Pfizer)
Synthetic prostaglandin E1 analog that protects gastric mucosa by inhibiting acid secretion and stimulating mucus/bicarbonate, also causes uterine contraction. - Methergine · University of South Florida
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Postpartum hemorrhage patent landscape — cliff calendar, originator estates, attackable patents
- Postpartum hemorrhage treatment landscape brief
- Postpartum hemorrhage treatment updates RSS
Frequently asked questions about Postpartum hemorrhage
What drugs treat Postpartum hemorrhage?
Tracked treatments include Oxytocin 5 Usp Units In Dextrose 5%, Ergobasine, Methergine, Cytotec, Hemabate.
What is the treatment for Postpartum hemorrhage?
Standard treatment for Postpartum hemorrhage includes Oxytocin 5 Usp Units In Dextrose 5%, Ergobasine, Methergine, Cytotec, Hemabate. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Postpartum hemorrhage patent cliff · Postpartum hemorrhage CI report
- Treatment: Oxytocin 5 Usp Units In Dextrose 5% · Fresenius Kabi
- Treatment: Ergobasine · Cairo University
- Treatment: Methergine · Edison Theraps Llc
- Treatment: Cytotec · Pfizer
- Treatment: Hemabate · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing